Acquiring Company
Teva Pharmaceutical Industries Ltd
Acquired Company
Emalex Biosciences
Tel Aviv
ChicagoManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Teva Pharmaceutical Industries Ltd. has officially closed the acquisition of Emalex Biosciences. This acquisition aims to enhance Teva's late-stage pipeline with ecopipam, a treatment for Tourette syndrome. Teva's strategy is to continue transforming into a leading innovative biopharmaceutical company, addressing critical patient needs.
Who to call at Teva Pharmaceutical Industries Ltd, and when
When Teva Pharmaceutical Industries Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Teva Pharmaceutical Industries Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Teva Pharmaceutical Industries Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Teva Pharmaceutical Industries Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Teva Pharmaceutical Industries Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Emalex Biosciences?
Emalex Biosciences was acquired by Teva Pharmaceutical Industries Ltd, based in Tel Aviv. The deal was reported on June 10, 2026. Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of people worldwide. Teva Pharmaceutical Industries Ltd is publicly traded (TEVA) and operates in Manufacturing.
When did Teva Pharmaceutical Industries Ltd acquire Emalex Biosciences?
Teva Pharmaceutical Industries Ltd's acquisition of Emalex Biosciences was reported on June 10, 2026. Teva Pharmaceutical Industries Ltd. has officially closed the acquisition of Emalex Biosciences. This acquisition aims to enhance Teva's late-stage pipeline with ecopipam, a treatment for Tourette syndrome. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Emalex Biosciences do?
Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. It is privately held, and is based in Chicago.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.